Viz HCM vs WellDoc BlueStar

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Viz.ai
VS
by WellDoc

AI Verdict

Viz HCM is designed for real-time AI-powered detection and care coordination for a specific cardiac condition (Hypertrophic Cardiomyopathy) within hospital systems, primarily aiding clinicians in diagnosis and workflow. In contrast, WellDoc BlueStar is a patient-facing digital health solution for managing multiple chronic cardiometabolic diseases, offering personalized coaching and insights via a mobile app. While both leverage AI in cardiology and are FDA-cleared, they address different stages of care and target distinct user groups.

Choose Viz HCM if…

Choose Viz HCM if your hospital or health system requires an FDA-cleared AI solution for real-time detection of suspected Hypertrophic Cardiomyopathy directly from ECGs. This tool is ideal for rapidly identifying at-risk patients and coordinating their care across multidisciplinary teams, significantly reducing time to diagnosis and treatment for HCM.

View Viz HCM →

Choose WellDoc BlueStar if…

Choose WellDoc BlueStar if you are a health plan, health system, or employer seeking a comprehensive digital health solution for chronic disease management across multiple cardiometabolic conditions. This platform excels at providing AI-driven personalized coaching, integrating with patient-connected devices, and empowering individuals with diabetes, hypertension, and heart failure to better manage their health.

View WellDoc BlueStar →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Viz HCM WellDoc BlueStar
Deployment Unknown Mobile app, web-based HCP software, and integration with existing systems.
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

WellDoc BlueStar

WellDoc BlueStar offers a highly interactive and personalized mobile experience for patients, integrating with a wide array of connected devices and providing AI-driven coaching and data logging. While Viz HCM focuses on seamless integration into clinical workflows for providers, WellDoc's direct patient engagement features and emphasis on ease of use for the end-user give it an edge in overall usability for its target audience.

Clinical Value

Viz HCM

Viz HCM provides critical, real-time AI-powered detection of a life-threatening cardiac condition (HCM) from ECGs, significantly reducing diagnosis time and coordinating care. Its direct impact on early detection and rapid intervention for a high-acuity disease, supported by extensive clinical validation, gives it a slight edge in immediate, life-saving clinical value.

Pricing & Value

Viz HCM

Viz HCM clearly outlines CMS reimbursement for its services, offering a direct and transparent financial pathway for hospitals to offset costs and demonstrate value. This explicit reimbursement mechanism provides a significant advantage in terms of pricing transparency and immediate financial value for adopting institutions. WellDoc BlueStar's enterprise pricing lacks such public details, making its direct financial value harder to quantify without direct vendor engagement.

Enterprise Readiness

Viz HCM

Viz HCM demonstrates superior enterprise readiness through its explicit focus on deep integration with core hospital IT systems like EHR and PACS, and its proven deployment across a large number of U.S. hospitals. While WellDoc BlueStar also targets health systems and offers a provider portal, Viz HCM's established track record of seamless integration into complex hospital workflows for critical care coordination gives it a stronger enterprise footprint.

Innovation

WellDoc BlueStar

WellDoc BlueStar exhibits broader innovation by applying AI to personalized, multi-condition chronic disease management, integrating with a vast ecosystem of connected devices, and providing direct patient coaching and insulin dose recommendations. While Viz HCM's specialized AI for HCM detection is highly impactful, WellDoc's comprehensive and scalable approach to empowering patients across multiple chronic conditions represents a wider scope of innovation in digital health.

Support & Docs

Viz HCM

Viz HCM clearly outlines a comprehensive support structure including a dedicated customer success team, clinical and workflow specialists, and a readily available knowledge base with tutorials and documentation. This structured and multi-faceted approach to customer and implementation support provides a more robust offering compared to WellDoc BlueStar's more general customer care contact information.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Viz HCM WellDoc BlueStar
Name Viz HCM WellDoc BlueStar
Company Viz.ai WellDoc
Primary Purpose AI tool for real-time ECG analysis to detect suspected Hypertrophic Cardiomyopathy (HCM) and coordinate cardiac care. AI-powered digital health solution for chronic disease management, offering personalized coaching and insights.
Target Conditions/Diseases Hypertrophic Cardiomyopathy (HCM) Diabetes, hypertension, heart failure, weight management, behavioral health.
Key AI Functionality AI-powered ECG analysis for HCM detection, real-time disease detection, mobile-based alerts, automated patient direction. AI-driven personalized coaching, multi-condition support, integration with connected devices, insulin dose recommendations.

Videos

Demos, reviews, and walkthroughs featuring Viz HCM and WellDoc BlueStar.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Viz HCM is an AI tool focused on real-time ECG analysis to detect suspected Hypertrophic Cardiomyopathy (HCM) and coordinate cardiac care, aiming to reduce diagnosis time. WellDoc BlueStar is an AI-powered digital health solution for chronic disease management, offering personalized coaching and insights for conditions such as diabetes, hypertension, and heart failure.
Viz HCM has CMS reimbursement available for CPT codes 0764T and 0765T, with a national payment rate of $128.90 effective January 1, 2025. WellDoc BlueStar operates on an enterprise pricing model, typically paid for by health plans, health systems, or employers.
Viz HCM is primarily designed for Cardiology, Emergency Medicine, and Hospital Medicine, focusing on acute detection and care coordination for HCM. WellDoc BlueStar supports Cardiology, Endocrinology, and Internal Medicine, with a focus on chronic disease management and patient engagement.
Viz HCM utilizes real-time ECG analysis for the detection of suspected HCM. WellDoc BlueStar integrates data from connected devices (e.g., BGM, CGM, BP cuffs) and provides AI-driven personalized coaching, real-time feedback, and insulin dose recommendations based on this logged data.
Viz HCM's core functionality includes AI-powered ECG analysis for HCM detection, mobile-based alerts to care teams, and automated direction of patients to appropriate specialists. WellDoc BlueStar offers AI-driven personalized coaching, multi-condition support, educational content, and a care team portal for providers to monitor patient progress.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.